Oral Squamous Cell Carcinoma Prognostic Factors for 147 Patients

147 OSCC patient records from a retrospective cohort study integrate metabolic metrics from 18F-FDG PET/CT, body composition (L3-SMI), and pathological features. The data was used to identify nodal-specific prognostic factors for overall and progression-free survival. The dataset was authored by Shihui Shen and last updated on 2026-03-17.

Use Cases

• Train survival prediction models based on tumor maximum standardized uptake value (T-SUVmax) for pN0 patients.
• Identify high-risk pN+ patients based on the number of positive lymph nodes and L3 skeletal muscle index (L3-SMI).
• Validate prognostic factors for oral squamous cell carcinoma using internal bootstrap validation methodology.
• Conduct comparative analysis of divergent prognostic drivers between pN0 and pN+ patient subgroups.

Strengths

• Dataset includes specific hazard ratios and p-values for key prognostic factors, such as T-SUVmax >13.27 (HR=10.24) for pN0 patients.
• Internal validation was performed using bootstrap resampling with 1000 repetitions to assess factor stability.
• Patient cohort is clearly stratified into 74 pN0 and 73 pN+ cases for comparative analysis.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect temporal or institutional bias inherent to the single retrospective study.

Provenance

Source

figshare, author Shihui Shen

Collection Method

Retrospective cohort study of patients who underwent curative resection and neck dissection.

Freshness

Last updated 2026-03-17 13:06:23; freshness should be verified.